---
aliases:
- (Kopelke et al., 2022)
author: Kopelke, Svenja and Kjaer, Troels W. and Tvilsted, Soeren and Schild, Steven
  E. and Bartscht, Tobias and Rades, Dirk
citekey: kopelke2022RiskFactorsSleep
date_added: '2025-03-23'
doi: 10.21873/invivo.12705
journal: In Vivo
title: Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas
year: '2022'

---
# Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas
- [PDF Link](zotero://open-pdf/library/items/4XLBBQVV)

Citation: [@kopelke2022RiskFactorsSleep]

***
# TL;DR (Summary)
- Prevalence of pre-treatment sleep problems was 66.7% among 57 patients with grade II-IV gliomas.
- Significant associations with sleep problems included female gender (p=0.023), presence of emotional problems (p=0.006), and ≥4 physical problems (p<0.001).
- A trend was observed for distress scores ≥5 (p=0.077).
- First study to evaluate sleep problems prior to radiochemotherapy specifically in patients with malignant gliomas.
- Authors suggest that the identified risk factors can be used to identify patients who would benefit from psychological support before starting radiochemotherapy.
- Emphasize the need for psychological support to improve patients' quality of life.
- The prevalence of sleep problems in this study was higher than in other cancer types and settings, indicating a unique challenge for glioma patients.
- No significant association was found between sleep problems and the timing of the COVID-19 pandemic (p=0.78).

# 中文摘要 (TL;DR)
- 在57名II-IV級腦膠質瘤患者的前期治療中，睡眠問題的流行率為66.7%。
- 與睡眠問題有顯著關聯的因素包括女性性別（p=0.023）、存在情緒問題（p=0.006）以及≥4個身體問題（p<0.001）。
- 對於≥5的壓力分數觀察到一種趨勢（p=0.077）。
- 首次研究評估惡性腦膠質瘤患者在放化療前睡眠問題的專門研究。
- 作者建議，可以利用所識別的風險因素來識別在開始放化療前需要心理支持的患者。
- 強調需要心理支持以改善患者的生活質量。
- 本研究中睡眠問題的流行率高於其他癌症類型和環境，表明腦膠質瘤患者面臨獨特的挑戰。
- 未發現睡眠問題與COVID-19大流行的時間有顯著關聯（p=0.78）。
